Clinical Trials Browser

Phase 3 × Sorafenib × Thoracic × Clear all

NCT00300885 2014-11-04

A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Terminated

926 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT00558636 2013-12-27

A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Terminated

91 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung